Related Experiment Video

Updated: Mar 8, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K

p53 Replacement Therapy for Cancer

Hiroshi Tazawa1,2, Shunsuke Kagawa2, Toshiyoshi Fujiwara3

  • 1Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, 700-8558, Japan.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|January 20, 2017
PubMed

Insights

Tumor suppressor gene (TSG) replacement therapy, particularly using the p53 gene, shows promise for treating cancers. This approach restores p53 function to combat tumor growth and enhance cell death signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Malignant tumors arise from genetic alterations in tumor suppressor genes (TSGs).
  • The p53 gene, a key TSG, regulates critical cellular processes and is frequently inactivated in human cancers.
  • Restoring wild-type p53 function via replacement therapy is a vital antitumor strategy.

Purpose of the Study:

  • To review p53 replacement therapy as an antitumor strategy.
  • To explore various p53 delivery systems and their therapeutic potential.
  • To discuss advancements in p53-mediated cell death pathways and bystander effects.

Main Methods:

  • Focus on four p53 transfer systems: cationic liposome-DNA complexes, replication-deficient adenovirus, replication-competent adenovirus, and protein transduction.
  • Analysis of molecular mechanisms underlying p53-mediated tumor suppression.
  • Review of therapeutic methods to enhance tumor cell death and bystander effects.

Main Results:

  • p53 replacement therapy utilizes diverse delivery systems to restore tumor suppressor gene function.
  • Understanding p53's role in cell cycle arrest, senescence, apoptosis, and autophagy is crucial.
  • Enhancing p53-mediated cell death signaling and bystander effects improves therapeutic outcomes.

Conclusions:

  • p53 replacement therapy is a promising strategy for p53-inactivated cancers.
  • Further exploration of p53's molecular mechanisms can optimize cancer treatment.
  • Developing effective strategies to enhance p53-mediated cell death is key for clinical success.
Keywords:
AdenovirusCancerGene therapyp53

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

290
Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K